Published by Michele Maatouk on 31st October 2025
(Sharecast News) - AIM-listed Genedrive said on Friday that shareholder David Nugent had shown "willingness" to make a cash injection into the point-of-care pharmacogenetic testing company.
URL: http://www.digitallook.com/dl/news/story/35463163/...